Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab.
Murakami N, Yoshimoto S, Matsumoto F, Ueno T, Ito Y, Watanabe S, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Saito Y, Itami J. Murakami N, et al. Among authors: matsumoto f. J Cancer Res Clin Oncol. 2015 Jan;141(1):177-84. doi: 10.1007/s00432-014-1801-5. Epub 2014 Aug 15. J Cancer Res Clin Oncol. 2015. PMID: 25119987
Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N, Matsumoto F, Yoshimoto S, Ito Y, Mori T, Ueno T, Tuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Inaba K, Igaki H, Itami J. Murakami N, et al. Among authors: matsumoto f. BMC Cancer. 2016 Mar 7;16:192. doi: 10.1186/s12885-016-2229-x. BMC Cancer. 2016. PMID: 26951089 Free PMC article.
All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.
Kobayashi K, Yoshimoto S, Matsumoto F, Ando M, Murakami N, Omura G, Fukasawa M, Matsumoto Y, Matsumura S, Akamatsu M, Hiraoka N, Eigitsu R, Mori T. Kobayashi K, et al. Among authors: matsumoto y, matsumoto f. Ann Surg Oncol. 2019 Jul;26(7):2294-2303. doi: 10.1245/s10434-019-07287-x. Epub 2019 Mar 21. Ann Surg Oncol. 2019. PMID: 30900104
Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Saito Y, Hayashi R, Iida Y, Mizumachi T, Fujii T, Matsumoto F, Beppu T, Yoshida M, Shinomiya H, Kamiyama R, Kitano M, Yokoshima K, Fujimoto Y, Hama T, Yamashita T, Okami K, Miura K, Fujisawa T, Sano D, Kato H, Minami S, Sugasawa M, Masuda M, Ota I, Iwae S, Kawata R, Monden N, Imai T, Asakage T, Okada M, Yoshikawa T, Tanioka K, Kitayama M, Doi M, Fujii S, Fujii M, Oridate N, Nakamizo M, Yoshimoto S, Homma A, Nibu KI, Yane K. Saito Y, et al. Among authors: matsumoto f. Cancer. 2020 Sep 15;126(18):4177-4187. doi: 10.1002/cncr.33062. Epub 2020 Jul 10. Cancer. 2020. PMID: 32648953 Free article.
Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence.
Kobayashi K, Yoshimoto S, Ando M, Matsumoto F, Murakami N, Omura G, Honma Y, Matsumoto Y, Ikeda A, Sakai A, Eguchi K, Ito A, Ryo E, Yatabe Y, Mori T. Kobayashi K, et al. Among authors: matsumoto y, matsumoto f. Oral Oncol. 2021 Feb;113:105091. doi: 10.1016/j.oraloncology.2020.105091. Epub 2020 Nov 26. Oral Oncol. 2021. PMID: 33249291
473 results